It has been reported that CD133 expression is associated with poor tumour differentiation and lymph node metastasis in tumour tissue, immunohistochemically determination and cell culture, and most probably poor prognosis of lung cancer (17, 28). Here, PROM1 is linked to lung carcinoma.